The Asia-Pacific infection control market size is forecasted to be growing at an impressive rate during the forecast period.
Factors such as the increasing number of surgical operations, the aging population, and the prevalence of chronic diseases drive the APAC infection control market. The APAC infection control industry is being bolstered by an increasing number of government policies, such as high-level prevention and rising healthcare spending. Furthermore, the APAC area has seen an increase in the incidence of hospital-acquired infections and an increase in surgical procedures, which is driving the infection control market in this region. On the other hand, a growing focus on food sterilization and disinfection and the introduction of advanced technologies boost the market growth.
Moreover, rising government and private-sector spending and support for better infection-control facilities and improved healthcare infrastructure are expected to drive demand growth in developing countries. Government initiatives in emerging countries such as India are providing directives to promulgate good rebate systems. The use of contaminated medical instruments for diagnostic and medicinal purposes is a significant source of HAIs. Besides, infection control measures introduced in healthcare settings will aid in the reduction of patient mortality. The World Health Organization (WHO) has recently issued healthcare guidelines for preventing and treating pandemic and epidemic-prone acute respiratory diseases, which is expected to uplift the market growth.
The primary concerns about the protection of processed surgical instruments were hazardous for patients and healthcare staff or clinicians, resulting in the spread of infection, thereby serving as a restriction factor and hampered the development of the infection control market in this region.
Impact of COVID-19 on the APAC infection control market:
As a result of the ongoing COVID-19 outbreak, there is unprecedented regional demand for advanced healthcare services, technologies, and infrastructure to treat the ill. Infection control measures, such as personal protective equipment, are in high need from most APAC countries to support an explosion of COVID-19 patients. Personal protective equipment (PPE) is used for healthcare professionals to protect themselves and their patients from contaminating and infecting others. However, with the highly infectious COVID-19 pandemic, the available face masks and gowns are inadequate. The global healthcare industry is experiencing a shortage of resources due to the disruption of the countries' exchange of activities.
As per the World Health Organization (WHO), 89 million medical masks will be needed each month. A 40 percent growth in manufacturing is projected to satisfy demand. The WHO also estimates that frontline staff would need approximately 7-10 percent of the world's surgical mask stock, if not more. The number increases to 76 million for examination gloves, while goggles are in high demand worldwide.
This research report on the APAC infection control market has been segmented and sub-segmented into the following categories.
By Products and Services:
Geographically, the APAC regional market is forecasted to be the fastest-growing region in the global market during the forecast period. The growth of this regional market is driven by the consistent number of strategic alliances embraced by major industry players to enhance their product portfolio and infection management capability.
The Chinese market is the world's leading manufacturer and exporter of masks, accounting for around half of global demand in regular years and 70% of exports even though China's mask capacity has risen by more than tenfold to 120 million per day, the global mask supply and demand deficit persist.
In the APAC area, India is one of the fastest-growing countries in the infection control industry. The demand is growing in this area due to the prevalence of chronic diseases, increased surgical procedures performed worldwide, and government initiatives. Technological advances and improved healthcare services, on the other hand, are more likely to drive demand growth in the infection growth market.
Over the projected period, the Japanese market is expected to have a modest share of the infection control market. The growing trend of emerging industry players in developed economies exporting to companies in the Asia Pacific region is also a key growth driver for the sector.
KEY MARKET PLAYERS:
3M, Dr. Wiegert, Tuttnauer, STERIS Corporation, Advanced Sterilization Products, Ecolab, Belimed AG, Cantel Medical Corporation, Matachana Group, Shinva Medical Instrument Co., Ltd., Whiteley Corporation, Ruhof Corporation, Getinge Group, and MMM Group are some of the dominating companies operating in the APAC infection control market.